ロード中...

Metformin causes cancer cell death through downregulation of p53-dependent differentiated embryo chondrocyte 1

BACKGROUND: Metformin is the most commonly used first-line medicine for type II diabetes mellitus. Acting via AMP-activated protein kinase, it has been used for more than 60 years and has an outstanding safety record. Metformin also offers protection against cancer, but its precise mechanisms remain...

詳細記述

保存先:
書誌詳細
出版年:J Biomed Sci
主要な著者: Hsieh Li, Shu-Man, Liu, Shu-Ting, Chang, Yung-Lung, Ho, Ching-Liang, Huang, Shih-Ming
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2018
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6238313/
https://ncbi.nlm.nih.gov/pubmed/30442142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-018-0478-5
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!